Brent Hatzis-Schoch

Insider Reports History

Location
Waltham, MA
Signature
/s/ Brent Hatzis-Schoch
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brent Hatzis-Schoch:

Company Role Class Num Shares Value Price $ Report Date Ownership
Black Diamond Therapeutics, Inc. Officer Title: Chief Operating Officer and General Counsel Common Stock 83,400 $208,500 $2.50 30 Jan 2025 Direct
Black Diamond Therapeutics, Inc. Officer Title: Chief Operating Officer and General Counsel Stock Option (Right to Buy) 250,000 21 Jan 2026 Direct

Insider Reports Filed by Brent Hatzis-Schoch

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BDTX Black Diamond Therapeutics, Inc. 21 Jan 2026 1 $0 4 Officer Title: Chief Operating Officer and General Counsel 23 Jan 2026, 16:05
BDTX Black Diamond Therapeutics, Inc. 30 Jan 2025 2 $0 4 Officer Title: Chief Operating Officer and General Counsel 31 Jan 2025, 16:35
BDTX Black Diamond Therapeutics, Inc. 14 Feb 2024 1 $0 4 Officer Title: Chief Operating Officer and General Counsel 15 Feb 2024, 17:38
BDTX Black Diamond Therapeutics, Inc. 13 Feb 2023 1 $0 4 Officer Title: Chief Operating Officer and General Counsel 15 Feb 2023, 15:10
BDTX Black Diamond Therapeutics, Inc. 15 Feb 2022 1 $0 4 Officer Title: Chief Operating Officer and General Counsel 17 Feb 2022, 15:21
BDTX Black Diamond Therapeutics, Inc. 12 May 2021 5 -$98,755 4 Chief Operating Officer and General Counsel 13 May 2021, 16:53